129 related articles for article (PubMed ID: 37337963)
1. Licochalcone A Derivatives as Selective Dipeptidyl Peptidase 4 Inhibitors with Anti-Inflammatory Effects.
Li CQ; Shi JH; Mu J; Wang AQ; Zou LW; Ge GB
J Nat Prod; 2023 Jul; 86(7):1824-1831. PubMed ID: 37337963
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H
Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763
[TBL] [Abstract][Full Text] [Related]
4. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
[TBL] [Abstract][Full Text] [Related]
5. Development of a
Yazbeck R; Jaenisch S; Squire M; Abbott CA; Parkinson-Lawrence E; Brooks DA; Butler RN
Sci Rep; 2019 Mar; 9(1):4906. PubMed ID: 30894647
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase 4 inhibitors: Applications in innate immunity?
Yazbeck R; Jaenisch SE; Abbott CA
Biochem Pharmacol; 2021 Jun; 188():114517. PubMed ID: 33722535
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors.
Zhang L; Su M; Li J; Ji X; Wang J; Li Z; Li J; Liu H
Chem Biol Drug Des; 2013 Feb; 81(2):198-207. PubMed ID: 22994702
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
11. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Yazbeck R; Howarth GS; Abbott CA
Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of dipeptidyl peptidase 4 inhibitors: anti-inflammatory and immunomodulatory effect and its application in diabetes mellitus.
Yang L; Yuan J; Zhou Z
Can J Diabetes; 2014 Dec; 38(6):473-9. PubMed ID: 25034244
[TBL] [Abstract][Full Text] [Related]
16. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
[TBL] [Abstract][Full Text] [Related]
17. Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein.
Castle AR; Kang SG; Eskandari-Sedighi G; Wohlgemuth S; Nguyen MA; Drucker DJ; Mulvihill EE; Westaway D
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2209815120. PubMed ID: 36574660
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, evaluation and molecular docking of prolyl-fluoropyrrolidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2013 Aug; 82(2):156-66. PubMed ID: 23581745
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats.
Al-Ghamdi MA; Moselhy SS
Environ Sci Pollut Res Int; 2023 Mar; 30(12):33942-33948. PubMed ID: 36496522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
